(NYSE: NVST) Envista Holdings's forecast annual revenue growth rate of 2.24% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Envista Holdings's revenue in 2025 is $2,510,600,000.On average, 7 Wall Street analysts forecast NVST's revenue for 2025 to be $433,205,701,709, with the lowest NVST revenue forecast at $431,064,026,619, and the highest NVST revenue forecast at $435,635,791,800. On average, 7 Wall Street analysts forecast NVST's revenue for 2026 to be $447,332,010,152, with the lowest NVST revenue forecast at $444,326,123,188, and the highest NVST revenue forecast at $451,614,843,768.
In 2027, NVST is forecast to generate $462,164,634,016 in revenue, with the lowest revenue forecast at $458,529,916,258 and the highest revenue forecast at $470,228,373,054.